

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | keratinization (GO:0031424) | 6.60996026 |
| 2 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 6.45377453 |
| 3 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.94756389 |
| 4 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 4.69280186 |
| 5 | glycosphingolipid catabolic process (GO:0046479) | 4.61973890 |
| 6 | establishment of skin barrier (GO:0061436) | 4.41938474 |
| 7 | oligosaccharide catabolic process (GO:0009313) | 4.37574853 |
| 8 | eosinophil chemotaxis (GO:0048245) | 4.34883801 |
| 9 | glycolipid catabolic process (GO:0019377) | 4.12592426 |
| 10 | regulation of water loss via skin (GO:0033561) | 4.00615976 |
| 11 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.93648709 |
| 12 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.91257193 |
| 13 | response to peptidoglycan (GO:0032494) | 3.85141549 |
| 14 | eosinophil migration (GO:0072677) | 3.84463678 |
| 15 | regulation of vitamin metabolic process (GO:0030656) | 3.78859502 |
| 16 | cellular response to arsenic-containing substance (GO:0071243) | 3.76513160 |
| 17 | negative regulation of interleukin-17 production (GO:0032700) | 3.74559273 |
| 18 | ceramide catabolic process (GO:0046514) | 3.73877069 |
| 19 | regulation of monocyte differentiation (GO:0045655) | 3.70584149 |
| 20 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.70389058 |
| 21 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.66216375 |
| 22 | osteoclast differentiation (GO:0030316) | 3.64602941 |
| 23 | regulation of chronic inflammatory response (GO:0002676) | 3.53772745 |
| 24 | negative regulation of lipid storage (GO:0010888) | 3.52331056 |
| 25 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.51441750 |
| 26 | regulation of mononuclear cell migration (GO:0071675) | 3.51256863 |
| 27 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.50497316 |
| 28 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.48733084 |
| 29 | myeloid dendritic cell differentiation (GO:0043011) | 3.45632544 |
| 30 | regulation of podosome assembly (GO:0071801) | 3.38467795 |
| 31 | regulation of cholesterol storage (GO:0010885) | 3.37909272 |
| 32 | lipoxygenase pathway (GO:0019372) | 3.32899602 |
| 33 | positive regulation of heat generation (GO:0031652) | 3.32501969 |
| 34 | keratinocyte differentiation (GO:0030216) | 3.32448061 |
| 35 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.32052762 |
| 36 | neutrophil activation involved in immune response (GO:0002283) | 3.31598916 |
| 37 | regulation of chemokine biosynthetic process (GO:0045073) | 3.28773217 |
| 38 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.27814346 |
| 39 | decidualization (GO:0046697) | 3.26917228 |
| 40 | membrane lipid catabolic process (GO:0046466) | 3.26201739 |
| 41 | protein localization to endosome (GO:0036010) | 3.24107589 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.22187229 |
| 43 | amino sugar catabolic process (GO:0046348) | 3.20494062 |
| 44 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.19248931 |
| 45 | monocyte chemotaxis (GO:0002548) | 3.13366656 |
| 46 | regulation of fever generation (GO:0031620) | 3.13340168 |
| 47 | response to thyroid hormone (GO:0097066) | 3.12661193 |
| 48 | sphingolipid catabolic process (GO:0030149) | 3.11477788 |
| 49 | positive regulation of osteoclast differentiation (GO:0045672) | 3.10052845 |
| 50 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.03319188 |
| 51 | granulocyte activation (GO:0036230) | 3.01002736 |
| 52 | response to lipoprotein particle (GO:0055094) | 2.83442430 |
| 53 | * positive regulation of interleukin-6 production (GO:0032755) | 2.82223146 |
| 54 | positive regulation of leukocyte degranulation (GO:0043302) | 2.82097430 |
| 55 | myeloid dendritic cell activation (GO:0001773) | 2.78787451 |
| 56 | positive regulation of macrophage differentiation (GO:0045651) | 2.77553990 |
| 57 | sphingosine metabolic process (GO:0006670) | 2.74887785 |
| 58 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.74395763 |
| 59 | positive regulation of extracellular matrix organization (GO:1903055) | 2.72941053 |
| 60 | macrophage activation involved in immune response (GO:0002281) | 2.72650934 |
| 61 | skin morphogenesis (GO:0043589) | 2.71291497 |
| 62 | regulation of monocyte chemotaxis (GO:0090025) | 2.70759774 |
| 63 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.70130383 |
| 64 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.68793593 |
| 65 | negative regulation of interferon-gamma production (GO:0032689) | 2.67575814 |
| 66 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.67504116 |
| 67 | regulation of interleukin-17 production (GO:0032660) | 2.66870356 |
| 68 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.66321256 |
| 69 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.66109098 |
| 70 | linoleic acid metabolic process (GO:0043651) | 2.65832435 |
| 71 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.64840437 |
| 72 | detection of other organism (GO:0098543) | 2.64263712 |
| 73 | positive regulation of bone resorption (GO:0045780) | 2.63877894 |
| 74 | positive regulation of bone remodeling (GO:0046852) | 2.63877894 |
| 75 | sphingoid metabolic process (GO:0046519) | 2.63310794 |
| 76 | detection of bacterium (GO:0016045) | 2.62331059 |
| 77 | positive regulation of tissue remodeling (GO:0034105) | 2.62100269 |
| 78 | peptide cross-linking (GO:0018149) | 2.61782336 |
| 79 | cellular response to lipopolysaccharide (GO:0071222) | 2.60453089 |
| 80 | positive regulation of p38MAPK cascade (GO:1900745) | 2.59938994 |
| 81 | positive regulation of cholesterol efflux (GO:0010875) | 2.59743794 |
| 82 | * regulation of interleukin-6 production (GO:0032675) | 2.58817099 |
| 83 | positive regulation of mast cell activation (GO:0033005) | 2.56988899 |
| 84 | keratinocyte proliferation (GO:0043616) | 2.56960529 |
| 85 | phagosome maturation (GO:0090382) | 2.56753142 |
| 86 | germinal center formation (GO:0002467) | 2.55652587 |
| 87 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.55035585 |
| 88 | pinocytosis (GO:0006907) | 2.54031167 |
| 89 | T-helper 1 type immune response (GO:0042088) | 2.52874819 |
| 90 | positive regulation of type 2 immune response (GO:0002830) | 2.51578241 |
| 91 | cellular response to molecule of bacterial origin (GO:0071219) | 2.50232183 |
| 92 | chronic inflammatory response (GO:0002544) | 2.48285990 |
| 93 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.46843096 |
| 94 | regulation of natural killer cell activation (GO:0032814) | 2.46291530 |
| 95 | diol metabolic process (GO:0034311) | 2.46228991 |
| 96 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.45571056 |
| 97 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.44739186 |
| 98 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.44223537 |
| 99 | negative regulation of cytokine secretion (GO:0050710) | 2.43360164 |
| 100 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.43055688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.10843855 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.03770429 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.93173709 |
| 4 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.60418316 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.27213860 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.26801346 |
| 7 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.20976689 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.09077655 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94781715 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.89542863 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.82918709 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.82814522 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.46942857 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.45233210 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.43476574 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.35861687 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28151293 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.20292539 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.01653534 |
| 20 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.01261412 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89504281 |
| 22 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.85019235 |
| 23 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82677838 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82569177 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.79271484 |
| 26 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.74778200 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71132778 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70368423 |
| 29 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.70357209 |
| 30 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.70357209 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.69940243 |
| 32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.66419183 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.64895603 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63618852 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57660282 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56014555 |
| 37 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55255588 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51051387 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.49521324 |
| 40 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.48884520 |
| 41 | CJUN_26792858_Chip-Seq_BT549_Human | 1.45887155 |
| 42 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.42789495 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42277964 |
| 44 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.40269058 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36897522 |
| 46 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30670866 |
| 47 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.29309353 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28174972 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28134360 |
| 50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25867139 |
| 51 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24041779 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23232595 |
| 53 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.22668608 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21625196 |
| 55 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19890644 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17342140 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17050738 |
| 58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16542439 |
| 59 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.16131735 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15822875 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15394049 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14000347 |
| 63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13332194 |
| 64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12403938 |
| 65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12403938 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11074275 |
| 67 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10773954 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10091237 |
| 69 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08972122 |
| 70 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08491292 |
| 71 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07288598 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04767546 |
| 73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03241802 |
| 74 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00272318 |
| 75 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98660173 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97628391 |
| 77 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97333106 |
| 78 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96359003 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96019042 |
| 80 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.94870286 |
| 81 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93132341 |
| 82 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92648240 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92570064 |
| 84 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.92222221 |
| 85 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90321763 |
| 86 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90127628 |
| 87 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89430309 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88747157 |
| 89 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85692387 |
| 90 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85424952 |
| 91 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84747029 |
| 92 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84251935 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83919149 |
| 94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83553490 |
| 95 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.83318944 |
| 96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83266699 |
| 97 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.83171275 |
| 98 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.78814267 |
| 99 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78186953 |
| 100 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76862521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.77019790 |
| 2 | MP0009840_abnormal_foam_cell | 3.49251396 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.42691004 |
| 4 | MP0002796_impaired_skin_barrier | 3.39496972 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.37333981 |
| 6 | MP0006082_CNS_inflammation | 3.09603345 |
| 7 | MP0003453_abnormal_keratinocyte_physiol | 2.97867578 |
| 8 | MP0004510_myositis | 2.77397105 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.63920120 |
| 10 | MP0004947_skin_inflammation | 2.63399998 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.55819468 |
| 12 | MP0000343_altered_response_to | 2.45714188 |
| 13 | MP0003724_increased_susceptibility_to | 2.43641317 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.38570851 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.33461821 |
| 16 | MP0003436_decreased_susceptibility_to | 2.23282693 |
| 17 | MP0005451_abnormal_body_composition | 2.22911423 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 2.12964743 |
| 19 | MP0009785_altered_susceptibility_to | 2.07673927 |
| 20 | MP0001853_heart_inflammation | 2.05434409 |
| 21 | MP0005671_abnormal_response_to | 2.03011415 |
| 22 | MP0000604_amyloidosis | 2.02900139 |
| 23 | MP0010234_abnormal_vibrissa_follicle | 2.02144693 |
| 24 | MP0002998_abnormal_bone_remodeling | 2.02079280 |
| 25 | MP0002419_abnormal_innate_immunity | 1.98402661 |
| 26 | MP0008004_abnormal_stomach_pH | 1.98185231 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.95931725 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.95364610 |
| 29 | MP0005000_abnormal_immune_tolerance | 1.85094565 |
| 30 | MP0001790_abnormal_immune_system | 1.77398980 |
| 31 | MP0005387_immune_system_phenotype | 1.77398980 |
| 32 | MP0005275_abnormal_skin_tensile | 1.74415348 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.64956555 |
| 34 | MP0009764_decreased_sensitivity_to | 1.64909635 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.64094304 |
| 36 | MP0005025_abnormal_response_to | 1.62802836 |
| 37 | MP0001216_abnormal_epidermal_layer | 1.62377283 |
| 38 | MP0005501_abnormal_skin_physiology | 1.60895383 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.58683416 |
| 40 | MP0001835_abnormal_antigen_presentation | 1.53422277 |
| 41 | MP0000383_abnormal_hair_follicle | 1.48986826 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.48474065 |
| 43 | MP0003075_altered_response_to | 1.40817996 |
| 44 | MP0006054_spinal_hemorrhage | 1.39997468 |
| 45 | MP0003690_abnormal_glial_cell | 1.37540722 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.37522855 |
| 47 | MP0002723_abnormal_immune_serum | 1.33075391 |
| 48 | MP0005647_abnormal_sex_gland | 1.29147432 |
| 49 | MP0005023_abnormal_wound_healing | 1.27482531 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 1.26350303 |
| 51 | MP0000579_abnormal_nail_morphology | 1.24609857 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.24102437 |
| 53 | MP0003448_altered_tumor_morphology | 1.22025732 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.20409363 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.20409363 |
| 56 | MP0001542_abnormal_bone_strength | 1.17648706 |
| 57 | MP0003091_abnormal_cell_migration | 1.17114268 |
| 58 | MP0003329_amyloid_beta_deposits | 1.16809821 |
| 59 | MP0000371_diluted_coat_color | 1.14831975 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.14717960 |
| 61 | MP0002332_abnormal_exercise_endurance | 1.12658863 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.12552407 |
| 63 | MP0001851_eye_inflammation | 1.11077338 |
| 64 | MP0009379_abnormal_foot_pigmentation | 1.10220536 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.09324158 |
| 66 | MP0009278_abnormal_bone_marrow | 1.09296206 |
| 67 | MP0002405_respiratory_system_inflammati | 1.09028641 |
| 68 | MP0001800_abnormal_humoral_immune | 1.09004972 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 1.07374421 |
| 70 | MP0002254_reproductive_system_inflammat | 1.05899142 |
| 71 | MP0005164_abnormal_response_to | 1.05726835 |
| 72 | MP0000920_abnormal_myelination | 1.05506029 |
| 73 | MP0005310_abnormal_salivary_gland | 1.05401235 |
| 74 | MP0002420_abnormal_adaptive_immunity | 1.04047360 |
| 75 | MP0001819_abnormal_immune_cell | 1.03448024 |
| 76 | MP0003195_calcinosis | 0.97314650 |
| 77 | MP0008469_abnormal_protein_level | 0.94149984 |
| 78 | MP0000858_altered_metastatic_potential | 0.92510805 |
| 79 | MP0003828_pulmonary_edema | 0.91651671 |
| 80 | MP0005166_decreased_susceptibility_to | 0.91458507 |
| 81 | MP0005595_abnormal_vascular_smooth | 0.87417201 |
| 82 | MP0001191_abnormal_skin_condition | 0.86582121 |
| 83 | MP0000685_abnormal_immune_system | 0.84251294 |
| 84 | MP0000569_abnormal_digit_pigmentation | 0.83981683 |
| 85 | MP0010386_abnormal_urinary_bladder | 0.82547278 |
| 86 | MP0002098_abnormal_vibrissa_morphology | 0.79513929 |
| 87 | MP0010771_integument_phenotype | 0.78361647 |
| 88 | MP0009763_increased_sensitivity_to | 0.76903456 |
| 89 | MP0001727_abnormal_embryo_implantation | 0.75701685 |
| 90 | MP0003879_abnormal_hair_cell | 0.75680993 |
| 91 | MP0005390_skeleton_phenotype | 0.74007124 |
| 92 | MP0008874_decreased_physiological_sensi | 0.72439114 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.72340223 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.71312456 |
| 95 | MP0003795_abnormal_bone_structure | 0.71289669 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.69680337 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.68929846 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.68929144 |
| 99 | MP0005257_abnormal_intraocular_pressure | 0.68704543 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.67714622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.61170202 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.61170202 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.61170202 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 4.95798257 |
| 5 | Increased IgE level (HP:0003212) | 4.57613995 |
| 6 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.55616688 |
| 7 | Parakeratosis (HP:0001036) | 4.32727711 |
| 8 | Abnormality of nail color (HP:0100643) | 4.28908813 |
| 9 | Nuclear cataract (HP:0100018) | 4.27949652 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.20423141 |
| 11 | Loss of speech (HP:0002371) | 4.17817908 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.12241977 |
| 13 | Myocardial infarction (HP:0001658) | 3.95923348 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 3.94763981 |
| 15 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.85346708 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.79968413 |
| 17 | Neurofibrillary tangles (HP:0002185) | 3.77763308 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.77660052 |
| 19 | Erythroderma (HP:0001019) | 3.64827011 |
| 20 | Disinhibition (HP:0000734) | 3.62122948 |
| 21 | Palmoplantar hyperkeratosis (HP:0000972) | 3.43741363 |
| 22 | Axonal loss (HP:0003447) | 3.38381168 |
| 23 | Thick nail (HP:0001805) | 3.35603344 |
| 24 | Pustule (HP:0200039) | 3.26886341 |
| 25 | Palmar hyperkeratosis (HP:0010765) | 3.20857337 |
| 26 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.19991992 |
| 27 | Interstitial pulmonary disease (HP:0006530) | 3.16906717 |
| 28 | Tetraparesis (HP:0002273) | 3.12588471 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 3.07202365 |
| 30 | Erythema (HP:0010783) | 3.05863957 |
| 31 | Mutism (HP:0002300) | 2.97841734 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 2.94995267 |
| 33 | Cerebral inclusion bodies (HP:0100314) | 2.91843207 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 2.86018467 |
| 35 | Gangrene (HP:0100758) | 2.77128721 |
| 36 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.74954674 |
| 37 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.74954674 |
| 38 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.74954674 |
| 39 | Plantar hyperkeratosis (HP:0007556) | 2.65118681 |
| 40 | Stomatitis (HP:0010280) | 2.64576567 |
| 41 | Vertebral compression fractures (HP:0002953) | 2.59964758 |
| 42 | Mucopolysacchariduria (HP:0008155) | 2.56932111 |
| 43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.56932111 |
| 44 | Apathy (HP:0000741) | 2.56809710 |
| 45 | Diminished motivation (HP:0000745) | 2.54200959 |
| 46 | Oral leukoplakia (HP:0002745) | 2.42976159 |
| 47 | Purpura (HP:0000979) | 2.39914802 |
| 48 | Metaphyseal irregularity (HP:0003025) | 2.39654575 |
| 49 | Recurrent abscess formation (HP:0002722) | 2.39127462 |
| 50 | Alopecia of scalp (HP:0002293) | 2.35630123 |
| 51 | Increased serum ferritin (HP:0003281) | 2.33368821 |
| 52 | Corneal erosion (HP:0200020) | 2.32819111 |
| 53 | Osteolytic defects of the hand bones (HP:0009699) | 2.29898856 |
| 54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.29898856 |
| 55 | Petechiae (HP:0000967) | 2.28163232 |
| 56 | Prolonged neonatal jaundice (HP:0006579) | 2.25906515 |
| 57 | Hypohidrosis (HP:0000966) | 2.24354116 |
| 58 | Neuronal loss in central nervous system (HP:0002529) | 2.23755351 |
| 59 | Hepatosplenomegaly (HP:0001433) | 2.15988768 |
| 60 | Supranuclear gaze palsy (HP:0000605) | 2.14937480 |
| 61 | Hypergammaglobulinemia (HP:0010702) | 2.13494756 |
| 62 | Xanthomatosis (HP:0000991) | 2.10903644 |
| 63 | Paralysis (HP:0003470) | 2.06507493 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.04908094 |
| 65 | Bone pain (HP:0002653) | 1.98871308 |
| 66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.98768428 |
| 67 | Ectropion (HP:0000656) | 1.96638190 |
| 68 | Progressive neurologic deterioration (HP:0002344) | 1.94474812 |
| 69 | Onycholysis (HP:0001806) | 1.93121519 |
| 70 | Natal tooth (HP:0000695) | 1.93074773 |
| 71 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.92471730 |
| 72 | Nail dystrophy (HP:0008404) | 1.92062816 |
| 73 | Upper motor neuron abnormality (HP:0002127) | 1.90310076 |
| 74 | Nausea (HP:0002018) | 1.89350861 |
| 75 | Abnormality of secondary sexual hair (HP:0009888) | 1.88476331 |
| 76 | Abnormality of the axillary hair (HP:0100134) | 1.88476331 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 1.86965638 |
| 78 | Inappropriate behavior (HP:0000719) | 1.86571773 |
| 79 | Basal ganglia calcification (HP:0002135) | 1.84931395 |
| 80 | Dementia (HP:0000726) | 1.84192134 |
| 81 | Asymmetric septal hypertrophy (HP:0001670) | 1.84112811 |
| 82 | Abnormality of the costochondral junction (HP:0000919) | 1.83965041 |
| 83 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.83707248 |
| 84 | Premature loss of primary teeth (HP:0006323) | 1.81799928 |
| 85 | Keratoconjunctivitis sicca (HP:0001097) | 1.81532791 |
| 86 | Protuberant abdomen (HP:0001538) | 1.79084046 |
| 87 | Thin bony cortex (HP:0002753) | 1.79020352 |
| 88 | Pruritus (HP:0000989) | 1.77832963 |
| 89 | Orchitis (HP:0100796) | 1.77250945 |
| 90 | Optic neuritis (HP:0100653) | 1.75510517 |
| 91 | Retrobulbar optic neuritis (HP:0100654) | 1.75510517 |
| 92 | Hypotrichosis (HP:0001006) | 1.74376610 |
| 93 | Urticaria (HP:0001025) | 1.70186821 |
| 94 | Zonular cataract (HP:0010920) | 1.70142569 |
| 95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.69731513 |
| 96 | Malnutrition (HP:0004395) | 1.68770939 |
| 97 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.68515604 |
| 98 | Recurrent skin infections (HP:0001581) | 1.63940358 |
| 99 | Amyloidosis (HP:0011034) | 1.63829793 |
| 100 | Skin nodule (HP:0200036) | 1.60462444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 7.02970327 |
| 2 | MOS | 3.14794646 |
| 3 | DDR2 | 3.10211035 |
| 4 | NME2 | 2.85960969 |
| 5 | TAOK2 | 2.79919374 |
| 6 | GRK7 | 2.72724668 |
| 7 | MAP3K3 | 2.46472401 |
| 8 | MAP3K14 | 2.24537767 |
| 9 | TBK1 | 2.02666099 |
| 10 | ERBB4 | 1.99896381 |
| 11 | TAOK1 | 1.83384670 |
| 12 | STK24 | 1.79647993 |
| 13 | BMPR2 | 1.76220921 |
| 14 | FGR | 1.73631553 |
| 15 | RIPK4 | 1.72139667 |
| 16 | MAP3K11 | 1.71614197 |
| 17 | CSK | 1.71328533 |
| 18 | ABL2 | 1.70190982 |
| 19 | IRAK4 | 1.66078285 |
| 20 | PIM2 | 1.61767248 |
| 21 | IKBKB | 1.61693789 |
| 22 | ACVR1B | 1.59799631 |
| 23 | TGFBR2 | 1.51872257 |
| 24 | IRAK2 | 1.51825444 |
| 25 | MATK | 1.41203782 |
| 26 | ADRBK2 | 1.39261210 |
| 27 | TRPM7 | 1.33992970 |
| 28 | BLK | 1.29216965 |
| 29 | ZAP70 | 1.27934528 |
| 30 | MAPK15 | 1.23005029 |
| 31 | CDC42BPA | 1.22723722 |
| 32 | MAP2K3 | 1.16290354 |
| 33 | IKBKE | 1.15783792 |
| 34 | RIPK1 | 1.13892601 |
| 35 | IRAK1 | 1.10465105 |
| 36 | PRPF4B | 1.09222920 |
| 37 | LIMK1 | 1.07949736 |
| 38 | BMX | 1.04685215 |
| 39 | MAP3K1 | 1.01789096 |
| 40 | CHUK | 0.98865063 |
| 41 | PKN1 | 0.97482522 |
| 42 | MARK3 | 0.96572443 |
| 43 | TTN | 0.90038336 |
| 44 | TYK2 | 0.88329433 |
| 45 | TAOK3 | 0.87741885 |
| 46 | TXK | 0.87694802 |
| 47 | SIK3 | 0.84773928 |
| 48 | MAP3K9 | 0.82081784 |
| 49 | MAP3K13 | 0.81932631 |
| 50 | JAK3 | 0.81637220 |
| 51 | CAMKK2 | 0.80284029 |
| 52 | PDGFRA | 0.80096572 |
| 53 | ERBB3 | 0.79775618 |
| 54 | TESK2 | 0.78556960 |
| 55 | PAK6 | 0.74488068 |
| 56 | MAP3K5 | 0.74387731 |
| 57 | TGFBR1 | 0.72438562 |
| 58 | PDGFRB | 0.72150476 |
| 59 | MAPK7 | 0.68528770 |
| 60 | MAP3K6 | 0.67470980 |
| 61 | PDK2 | 0.67358379 |
| 62 | TESK1 | 0.66712839 |
| 63 | JAK1 | 0.64441469 |
| 64 | PAK4 | 0.62673442 |
| 65 | ERN1 | 0.59901362 |
| 66 | SYK | 0.59540990 |
| 67 | TYRO3 | 0.58895537 |
| 68 | HCK | 0.56835021 |
| 69 | STK10 | 0.56258489 |
| 70 | CAMK1D | 0.56031043 |
| 71 | ABL1 | 0.55562252 |
| 72 | PAK2 | 0.53937680 |
| 73 | MAPK12 | 0.52431565 |
| 74 | PRKG2 | 0.51855838 |
| 75 | SGK3 | 0.51483370 |
| 76 | JAK2 | 0.49200352 |
| 77 | MAPK4 | 0.48142740 |
| 78 | GSK3A | 0.47937978 |
| 79 | MAP4K1 | 0.47413189 |
| 80 | CSF1R | 0.46332702 |
| 81 | PBK | 0.45878185 |
| 82 | LYN | 0.45841708 |
| 83 | CAMK1G | 0.45817406 |
| 84 | MAP2K6 | 0.45244781 |
| 85 | NEK9 | 0.44707113 |
| 86 | MAP3K2 | 0.44266717 |
| 87 | DYRK3 | 0.43222729 |
| 88 | CDK6 | 0.39798626 |
| 89 | ARAF | 0.38655455 |
| 90 | LATS2 | 0.37508528 |
| 91 | CAMK2G | 0.37237753 |
| 92 | MAPKAPK2 | 0.35029602 |
| 93 | STK3 | 0.34861491 |
| 94 | FRK | 0.34327163 |
| 95 | LCK | 0.33982373 |
| 96 | MST4 | 0.32239288 |
| 97 | MAPK11 | 0.31351084 |
| 98 | SIK1 | 0.31011420 |
| 99 | PDPK1 | 0.30601605 |
| 100 | PLK2 | 0.28899320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.74531592 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.17295944 |
| 3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.94129798 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.51349321 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.46925546 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19581660 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.08727402 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.04600689 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.96423270 |
| 10 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.94785695 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.93566925 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91790177 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.84355731 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.80565000 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78203686 |
| 16 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.76239463 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.72685837 |
| 18 | Salmonella infection_Homo sapiens_hsa05132 | 1.63865507 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.59342272 |
| 20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.58910738 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.54773690 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 1.53711833 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52695455 |
| 24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46833647 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46547212 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.46055030 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.43904010 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.39651498 |
| 29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38447483 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.37798691 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.34357321 |
| 32 | Bladder cancer_Homo sapiens_hsa05219 | 1.34005185 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.33011373 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.32179284 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.21579213 |
| 36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.20800974 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.19040536 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16007710 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13244168 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10959771 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04869968 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.00762974 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 0.97896469 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.97753484 |
| 45 | Amoebiasis_Homo sapiens_hsa05146 | 0.97716178 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92084393 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91595596 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89728396 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86113011 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.84914478 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84131216 |
| 52 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.82846857 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82719046 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81531764 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.80506817 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79480202 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 0.78627083 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78548028 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75169695 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.74905102 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.70487970 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70030126 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69245651 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68915770 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68083793 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.66950581 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65866351 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.65645767 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65348491 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64818137 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63537131 |
| 72 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.62952661 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60930900 |
| 74 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60740322 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60627737 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58563109 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58175410 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.56627624 |
| 79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56505276 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56156362 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55914221 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54162077 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50515927 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49120652 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48364346 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46963513 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46709723 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46121970 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44807759 |
| 90 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44505152 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43952996 |
| 92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41877057 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | 0.38239575 |
| 94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37205329 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35800808 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34177119 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30668178 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30004813 |
| 99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.29550230 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28771412 |

